Nektar Management to Speak at Investor Conferences

Nektar Therapeutics, a biotechnology company based in San Francisco, has announced its participation in two significant investor conferences. The company will present at the Jefferies Healthcare Conference in New York City on June 6, 2024, at 3:30 p.m. Eastern Time (12:30 p.m. Pacific Time). Additionally, Nektar will be featured at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 10, 2024, at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). These presentations will be available to the public via webcast, accessible through the Investor Events section on Nektar's website. The webcasts will remain available for replay until July 6, 2024, and July 10, 2024, respectively.

Nektar Therapeutics is a clinical-stage biotechnology firm dedicated to developing therapies aimed at addressing the root causes of immunological dysfunctions in autoimmune and chronic inflammatory diseases. The company's lead candidate, rezpegaldesleukin (REZPEG or NKTR-358), represents a novel approach as a first-in-class regulatory T cell stimulator. This potential treatment is currently undergoing Phase 2b clinical trials targeting atopic dermatitis and alopecia areata.

In addition to REZPEG, Nektar's pipeline includes NKTR-0165, a preclinical candidate characterized as a bivalent tumor necrosis factor receptor type II agonist antibody. This candidate is aimed at modulating immune responses for therapeutic benefit. Furthermore, Nektar is actively exploring the potential of NKTR-255, an investigational IL-15 receptor agonist. NKTR-255 is engineered to enhance the immune system's natural capability to combat cancer and is being investigated in multiple ongoing clinical trials.

Nektar Therapeutics collaborates with various partners to advance its pipeline and explore new therapeutic avenues. The company's headquarters are located in San Francisco, California.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!